Incyte
INCY
$51.74
Share price
0.17%
Change (1 day)
-31.24%
Change (1 year)
Categories
EPS for Incyte (INCY)
EPS in 2023 (TTM): $1.90
According to Incyte's latest financial reports the company's current EPS (TTM) is $1.90. In 2022 the company made an earnings per share (EPS) of $1.54 a decrease over its 2021 EPS that were of $4.29.
EPS history for Incyte from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.90 | 23.38% |
| 2022 | $1.54 | -64.1% |
| 2021 | $4.29 | -408.63% |
| 2020 | -$1.39 | -166.83% |
| 2019 | $2.08 | 300% |
| 2018 | $0.52 | -133.33% |
| 2017 | -$1.56 | -378.57% |
| 2016 | $0.56 | 2700% |
| 2015 | $0.02000 | -106.67% |
| 2014 | -$0.30 | -44.44% |
| 2013 | -$0.54 | 50% |
| 2012 | -$0.36 | -75.68% |
| 2011 | -$1.48 | 469.23% |
| 2010 | -$0.26 | -87.38% |
| 2009 | -$2.06 | 4.04% |
| 2008 | -$1.98 | 92.23% |
| 2007 | -$1.03 | 15.73% |
| 2006 | -$0.89 | -27.64% |
| 2005 | -$1.23 | -44.34% |
| 2004 | -$2.21 | -5.56% |
| 2003 | -$2.34 | 15.27% |
| 2002 | -$2.03 | -26.71% |
| 2001 | -$2.77 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $3.74 | 96.84% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | -2.11% | 🇺🇸 USA |
 Eli Lilly LLY | $5.43 | 185.75% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | 644.74% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $1.57 | -17.37% | 🇺🇸 USA |
 Geron GERN | -$0.34 | -117.89% | 🇺🇸 USA |
 CTI BioPharma
CTIC | -$0.58 | -130.53% | 🇺🇸 USA |
 AVEO Oncology
AVEO | -$0.84 | -144.21% | 🇺🇸 USA |
 Ardelyx ARDX | -$0.12 | -106.32% | 🇺🇸 USA |